Avinger announces presentations by key opinion leaders at new cardiovascular horizons annual conference

Redwood city, ca / accesswire / june 6, 2022 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of peripheral artery disease (pad), today announced two podium presentations featuring the company's lumivascular technology at the new cardiovascular horizons (ncvh) annual conference, which took place may 31 through june 3 in new orleans. key opinion leaders in the fields of interventional cardiology and endovascular interventions highlighted avinger's lumivascular technology in the following sessions: dr. ian cawich, an interventional cardiologist and director of the vascular and vein institute at arkansas heart hospital in little rock, highlighted the entire portfolio of avinger's proprietary oct-guided technologies, including the new lightbox 3 imaging console, in his session, "oct-guidance for cto crossing and atherectomy.
AVGR Ratings Summary
AVGR Quant Ranking